Colgate-Palmolive (NYSE:CL) Shares Bought by AMF Tjanstepension AB

AMF Tjanstepension AB increased its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1,088.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,569,394 shares of the company's stock after buying an additional 2,353,268 shares during the period. Colgate-Palmolive comprises 1.7% of AMF Tjanstepension AB's investment portfolio, making the stock its 21st largest holding. AMF Tjanstepension AB owned approximately 0.31% of Colgate-Palmolive worth $233,584,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in CL. State Street Corp increased its position in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the period. Geode Capital Management LLC increased its holdings in Colgate-Palmolive by 2.8% during the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock worth $2,095,325,000 after purchasing an additional 552,949 shares during the period. Massachusetts Financial Services Co. MA raised its position in Colgate-Palmolive by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company's stock valued at $988,997,000 after purchasing an additional 557,492 shares in the last quarter. Barclays PLC boosted its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after buying an additional 2,132,747 shares during the period. Finally, FMR LLC grew its position in shares of Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after buying an additional 2,674,807 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded down $3.39 during midday trading on Wednesday, hitting $90.71. 9,117,581 shares of the company's stock were exchanged, compared to its average volume of 4,182,153. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market cap of $73.61 billion, a price-to-earnings ratio of 25.77, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The firm's 50 day simple moving average is $89.03 and its 200 day simple moving average is $94.99.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company earned $0.87 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently weighed in on CL. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a report on Tuesday, January 7th. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a report on Monday, February 3rd. Finally, TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.